The U.S. Food and Drug management simply authorized bremelanotide as an innovative new treatment that is pharmaceutical pre-menopausal females with low libido. Marketed beneath the name brand Vyleesi, the injectable medicine is utilized to take care of exactly just what happens to be called hypoactive sexual desire disorder (HSDD). It’s the second libido-enhancing medicine on industry for females. (the very first, Addyi, had been authorized in 2015 and is a once-a-day capsule made.. Read More